Literature DB >> 9834189

The DAF-3 Smad binds DNA and represses gene expression in the Caenorhabditis elegans pharynx.

J D Thatcher1, C Haun, P G Okkema.   

Abstract

Gene expression in the pharyngeal muscles of Caenorhabditis elegans is controlled in part by organ-specific signals, which in the myo-2 gene target a short DNA sequence termed the C subelement. To identify genes contributing to these signals, we performed a yeast one-hybrid screen for cDNAs encoding factors that bind the C subelement. One clone recovered was from daf-3, which encodes a Smad most closely related to vertebrate Smad4. We demonstrated that DAF-3 binds C subelement DNA directly and specifically using gel mobility shift and DNase1 protection assays. Mutation of any base in the sequence GTCTG interfered with binding in the gel mobility shift assay, demonstrating that this pentanucleotide is a core recognition sequence for DAF-3 binding. daf-3 is known to promote formation of dauer larvae and this activity is negatively regulated by TGFbeta-like signaling. To determine how daf-3 affects C subelement enhancer activity in vivo, we examined expression a gfp reporter controlled by a concatenated C subelement oligonucleotide in daf-3 mutants and other mutants affecting the TGFbeta-like signaling pathway controlling dauer formation. Our results demonstrate that wild-type daf-3 can repress C subelement enhancer activity during larval development and, like its dauer-promoting activity, daf-3's repressor activity is negatively regulated by TGFbeta-like signaling. We have examined expression of this gfp reporter in dauer larvae and have observed no daf-3-dependent repression of C activity. These results suggest daf-3 directly regulates pharyngeal gene expression during non-dauer development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9834189     DOI: 10.1242/dev.126.1.97

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  26 in total

1.  Suppressors of transforming growth factor-beta pathway mutants in the Caenorhabditis elegans dauer formation pathway.

Authors:  T Inoue; J H Thomas
Journal:  Genetics       Date:  2000-11       Impact factor: 4.562

2.  Sensory experience and sensory activity regulate chemosensory receptor gene expression in Caenorhabditis elegans.

Authors:  E L Peckol; E R Troemel; C I Bargmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

3.  Molecular evolution of a developmental pathway: phylogenetic analyses of transforming growth factor-beta family ligands, receptors and Smad signal transducers.

Authors:  S J Newfeld; R G Wisotzkey; S Kumar
Journal:  Genetics       Date:  1999-06       Impact factor: 4.562

4.  Rapid selection of transgenic C. elegans using antibiotic resistance.

Authors:  Jennifer I Semple; Rosa Garcia-Verdugo; Ben Lehner
Journal:  Nat Methods       Date:  2010-08-22       Impact factor: 28.547

5.  A gateway-compatible yeast one-hybrid system.

Authors:  Bart Deplancke; Denis Dupuy; Marc Vidal; Albertha J M Walhout
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

6.  The C. elegans TGF-beta Dauer pathway regulates longevity via insulin signaling.

Authors:  Wendy M Shaw; Shijing Luo; Jessica Landis; Jasmine Ashraf; Coleen T Murphy
Journal:  Curr Biol       Date:  2007-09-27       Impact factor: 10.834

7.  C. elegans anaplastic lymphoma kinase ortholog SCD-2 controls dauer formation by modulating TGF-beta signaling.

Authors:  David J Reiner; Michael Ailion; James H Thomas; Barbara J Meyer
Journal:  Curr Biol       Date:  2008-08-05       Impact factor: 10.834

Review 8.  Transcriptional regulation of gene expression in C. elegans.

Authors:  Valerie Reinke; Michael Krause; Peter Okkema
Journal:  WormBook       Date:  2013-06-04

9.  Antagonistic Smad transcription factors control the dauer/non-dauer switch in C. elegans.

Authors:  Donha Park; Annette Estevez; Donald L Riddle
Journal:  Development       Date:  2010-02       Impact factor: 6.868

10.  Cell-specific monitoring of protein synthesis in vivo.

Authors:  Nikos Kourtis; Nektarios Tavernarakis
Journal:  PLoS One       Date:  2009-02-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.